Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis
Expert Reviews in Molecular Medicine · 2025 · 27
DOI: 10.1017/erm.2025.11 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 05.06.2025. Verfasst von Siran Yue und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes, Fibroblasts. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the synovial membrane, leading to cartilage destruction and bone erosion. Due to the complex pathogenesis of RA and the limitations of current therapies, increasing research attention has been directed towards novel strategies targeting fibroblast-like synoviocytes (FLS), which are key cellular components of the hyperplastic pannus. Recent studies have highlighted the pivotal role of FLS in the initiation and progression of RA, driven by their tumour-like transformation and the secretion of pro-inflammatory mediators, including cytokines, chemokines and matrix metalloproteinases. The aggressive phenotype of RA-FLS is marked by excessive proliferation, resistance to apoptosis, and enhanced migratory and invasive capacities. Consequently, FLS-targeted therapies represent a promising avenue for the development of next-generation RA treatments. The efficacy of such strategies – particularly those aimed at modulating FLS signalling pathways – has been demonstrated in both preclinical and clinical settings, underscoring their therapeutic potential. This review provides an updated overview of the pathogenic mechanisms and functional roles of FLS in RA, with a focus on critical signalling pathways under investigation, including Janus kinase/signal transducer and activator of transcription (JAK/STAT), mitogen-activated protein kinase (MAPK), nuclear factor kappa B (NF-κB), Notch and interleukin-1 receptor-associated kinase 4 (IRAK4). In addition, we discuss the emerging understanding of FLS-subset-specific contributions to immunometabolism and explore how computational biology is shaping novel targeted therapeutic strategies. A deeper understanding of the molecular and functional heterogeneity of FLS may pave the way for more effective and precise therapeutic interventions in RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
- Institute of Integrated Bioinfomedicine and Translational Science (IBTS), School of Chinese Medicine, https://ror.org/0145fw131Hong Kong Baptist University, Hong Kong SAR, China.
- Department of Rheumatology, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China.
- Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Siran Yue, Chao Liang
Zitieren
APA
Yue, S., Fan, J., Xie, D., Cao, C., Wang, Z., Huang, J., Qiu, F., Yang, X., He, D., Lu, A., & Liang, C. (2025). Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis. Expert Reviews in Molecular Medicine, 27. https://doi.org/10.1017/erm.2025.11
Vancouver
Yue S, Fan J, Xie D, Cao C, Wang Z, Huang J, et al. Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis. Expert Reviews in Molecular Medicine. 2025;27. doi:10.1017/erm.2025.11
BibTeX
@article{Yue2025,
author = {Yue, Siran and Fan, Junyu and Xie, Duoli and Cao, Chunhao and Wang, Zhuqian and Huang, Jie and Qiu, Fang and Yang, Xu and He, Dongyi and Lu, Aiping and Liang, Chao},
title = {Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis},
journal = {Expert Reviews in Molecular Medicine},
year = {2025},
volume = {27},
doi = {10.1017/erm.2025.11}
}
EUVIMED